「us」の検索結果
75件：66～70件目を表示
-
Product Development Policy | Research & Development | SENJU Pharmaceutica
rtension, and dry eye therapies. We also contributed to reducing the economic burden on patients by using various generic drugs and biosimilars. At the same time, eye diseases remain a significant glo...
http://www.senju.co.jp/english/rd/policy/ -
CEO Message | About Senju | SENJU Pharmaceutical
, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&D capabilities.Throughout our hi...
http://www.senju.co.jp/english/about/message.html -
aceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation cha...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
aceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation cha...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
R&D, drug and medical device manufacturing, and sells its products primarily in Europe and the US. The Corneal Esthesiometer Brill has been mainly distributed in Spain and the US. Senju will cont...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf